Total Payments
$2,311
2024 Payments
$750.69
Companies
29
Transactions
155
Medicare Patients
3,868
Medicare Billing
$136,488
Payment Breakdown by Category
Food & Beverage$2,311 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,311 | 155 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $469.41 | 36 | $0 (2024) |
| Lilly USA, LLC | $230.69 | 16 | $0 (2024) |
| Amgen Inc. | $152.51 | 9 | $0 (2024) |
| ABBVIE INC. | $147.52 | 12 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $137.15 | 8 | $0 (2021) |
| Exact Sciences Corporation | $102.62 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $99.67 | 7 | $0 (2024) |
| PFIZER INC. | $89.45 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $87.61 | 6 | $0 (2024) |
| Amarin Pharma Inc. | $84.81 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $750.69 | 47 | Novo Nordisk Inc ($191.95) |
| 2023 | $556.47 | 39 | Novo Nordisk Inc ($141.81) |
| 2022 | $313.64 | 21 | Merck Sharp & Dohme LLC ($41.05) |
| 2021 | $689.93 | 48 | Lilly USA, LLC ($143.50) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 2 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: PSYCHIATRY | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Obesity | ||||||
| 05/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: PSYCHIATRY | ||||||
| 05/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Cardiology | ||||||
| 05/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Gastroenterology | ||||||
| 05/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Obesity | ||||||
| 04/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Cardiology | ||||||
| 03/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Inflammation | ||||||
| 02/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Obesity | ||||||
| 02/06/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Cardiology | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Gastroenterology | ||||||
| 01/25/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Diabetes | ||||||
| 01/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Diabetes | ||||||
| 01/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Obesity | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Respiratory | ||||||
| 01/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/03/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.71 | General |
| 10/27/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.67 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,346 | 1,780 | $103,057 | $44,616 |
| 2022 | 23 | 1,361 | 1,802 | $105,936 | $50,448 |
| 2021 | 16 | 1,161 | 1,397 | $80,315 | $41,425 |
Total Patients
3,868
Total Services
4,979
Medicare Billing
$136,488
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 236 | 334 | $34,068 | $15,476 | 45.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 184 | $26,680 | $11,133 | 41.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 43 | 43 | $3,698 | $3,238 | 87.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 219 | 323 | $4,845 | $2,713 | 56.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 48 | 53 | $3,180 | $2,149 | 67.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 180 | 229 | $8,015 | $1,736 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 20 | $4,100 | $1,501 | 36.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 83 | 97 | $3,880 | $1,273 | 32.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 46 | $1,150 | $1,127 | 98.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 32 | 69 | $2,415 | $1,119 | 46.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 20 | $1,260 | $586.70 | 46.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 57 | $1,710 | $542.64 | 31.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 23 | 24 | $696.00 | $388.80 | 55.9% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 58 | 85 | $1,360 | $334.90 | 24.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $325.00 | $318.50 | 98.0% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 22 | 26 | $416.00 | $235.58 | 56.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 32 | $1,120 | $213.38 | 19.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 22 | $1,496 | $161.28 | 10.8% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 12 | 12 | $600.00 | $148.20 | 24.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 17 | 19 | $228.00 | $64.79 | 28.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 15 | 15 | $630.00 | $64.35 | 10.2% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 15 | 15 | $555.00 | $63.84 | 11.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 20 | 42 | $630.00 | $27.29 | 4.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 227 | 350 | $44,618 | $22,353 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 174 | 221 | $20,274 | $10,223 | 50.4% |
About Celeste Farmer, APRN
Celeste Farmer, APRN is a Family healthcare provider based in Brandenburg, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/04/2019. The National Provider Identifier (NPI) number assigned to this provider is 1851856876.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Celeste Farmer, APRN has received a total of $2,311 in payments from pharmaceutical and medical device companies, with $750.69 received in 2024. These payments were reported across 155 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,311).
As a Medicare-enrolled provider, Farmer has provided services to 3,868 Medicare beneficiaries, totaling 4,979 services with total Medicare billing of $136,488. Data is available for 3 years (2021–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Brandenburg, KY
- Active Since 02/04/2019
- Last Updated 02/20/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1851856876
Products in Payments
- Wegovy (Drug) $187.07
- NURTEC ODT (Drug) $166.87
- Ozempic (Drug) $160.14
- JARDIANCE (Drug) $126.26
- Cologuard Collection Kit (Device) $102.62
- Otezla (Drug) $86.34
- REXULTI (Drug) $85.51
- Vascepa (Drug) $84.81
- XIFAXAN (Drug) $82.18
- ELIQUIS (Drug) $79.32
- Rybelsus (Drug) $75.83
- UBRELVY (Drug) $75.28
- ENTRESTO (Drug) $70.81
- EMGALITY (Drug) $67.11
- TRINTELLIX (Drug) $60.75
- VOQUEZNA (Drug) $58.55
- TRULICITY (Drug) $54.39
- VRAYLAR (Drug) $54.30
- Repatha (Biological) $51.68
- FARXIGA (Drug) $47.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Brandenburg
Mrs. Mallory Lynch, Aprn, APRN
Family — Payments: $3,112
Family $3,112
Mr. Christopher Pickering, Np, NP
Family — Payments: $540.00
Family $540.00
Mrs. Stephanie Woosley, Aprn, APRN
Family — Payments: $511.99
Family $511.99
Christine Myers, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $317.62
Family $317.62
Marquita Brown, Aprn, APRN
Family — Payments: $256.31
Family $256.31
Mrs. Holly Schultz Pollock, Aprn, APRN
Family — Payments: $69.81
Family $69.81